VALYSTR · Stock research
Listed on NYSE. What the market is pricing into Takeda Pharmaceutical (TAK) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Pharmaceutical Preparations · market value about $66.3B · P/E 223.0 (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows